by | Jul 11, 2024 | Publications
Blood. 2024 Jul 11;144(2):129-131. doi: 10.1182/blood.2024024869. NO ABSTRACT PMID:38990540 | DOI:10.1182/blood.2024024869
by | Jul 11, 2024 | Publications
Haematologica. 2024 Jul 11. doi: 10.3324/haematol.2024.285470. Online ahead of print. ABSTRACT Multiple myeloma (MM) is a dreadful disease, marked by the uncontrolled proliferation of clonal plasma cells (PCs) within the bone marrow (BM). MM is characterized by a...
by | Jul 11, 2024 | Publications
Haematologica. 2024 Jul 11. doi: 10.3324/haematol.2024.285742. Online ahead of print. ABSTRACT The value of quantitative immunoprecipitation mass spectrometry (QIP-MS) to identify the M-protein is being investigated in patients with monoclonal gammopathies but no data...
by | Jul 11, 2024 | Publications
Saudi J Ophthalmol. 2024 Feb 22;38(2):185-187. doi: 10.4103/sjopt.sjopt_109_22. eCollection 2024 Apr-Jun. ABSTRACT Orbital manifestations are rarely observed in multiple myeloma (MM) and when they occur, they are often the first manifestation. We report a rare...
by | Jul 11, 2024 | Publications
Transl Cancer Res. 2024 Jun 30;13(6):2905-2912. doi: 10.21037/tcr-23-2336. Epub 2024 Jun 11. ABSTRACT BACKGROUND: As the overall survival (OS) of patients with multiple myeloma (MM) improves, the incidence of second primary malignancy (SPM) in long-term complications...
by | Jul 11, 2024 | Publications
Br J Haematol. 2024 Jul 10. doi: 10.1111/bjh.19640. Online ahead of print. ABSTRACT Venous thromboembolism (VTE) remains a significant cause of morbidity and mortality among multiple myeloma patients. Chang and colleagues’ findings indicate that factor Xa...
